The main objective of this study is to evaluate the need for universal, routine Day-1 Hb monitoring following elective primary knee arthroplasty by assessing the mean Hb drop, the rate of severe anaemia, and the rate of red blood cell (RBC) transfusions. This evidence concerns the gene GSTM1 and anemia.